These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2505189)

  • 1. Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy.
    Lui SF; Sweny P; Scoble JE; Varghese Z; Moorhead JF; Fernando ON
    Nephrol Dial Transplant; 1989; 4(5):387-9. PubMed ID: 2505189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation].
    Morales J; Mocarquer A; James E; Aris L; Herrera L; Morales I
    Rev Med Chil; 1987 Dec; 115(12):1172-5. PubMed ID: 3332925
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children.
    Orta-Sibu N; Chantler C; Bewick M; Haycock G
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):258-60. PubMed ID: 6807439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High- versus low-dose methylprednisolone for acute rejection episodes in renal transplantation.
    Park GD; Bartucci M; Smith MC
    Nephron; 1984; 36(2):80-3. PubMed ID: 6363949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spontaneous kidney transplant rupture--effect of immunosuppressive therapy on incidence of rupture].
    Oesterwitz H; Strobelt V; May G; Horlbeck R
    Z Urol Nephrol; 1990 Apr; 83(4):157-63. PubMed ID: 2378176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
    Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
    Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
    [No Abstract]   [Full Text] [Related]  

  • 7. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of methylprednisolone on first renal allograft rejection.
    Ahonen J; Häyry P; von Willebrand E; Eklund B; Lindström BL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):328-31. PubMed ID: 7022846
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not?
    Gray D; Shepherd H; Daar A; Oliver DO; Morris PJ
    Lancet; 1978 Jan; 1(8056):117-8. PubMed ID: 87551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft irradiation in the treatment of acute rejection of renal transplants: a randomized study.
    Pilepich MV; Anderson CB; Etheredge EE; Sicard GA; Melzer JS; Blum J
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):823-7. PubMed ID: 7050047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute rejection episodes in dog renal allograft recipients receiving cyclosporin A:ATG vs prednisolone.
    Kelly GE; Sheil AG
    Aust N Z J Surg; 1986 Mar; 56(3):251-5. PubMed ID: 3521569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of intravenous methylprednisolone with oral cyclosporin.
    Ubhi CS; Woodhouse L; Giles GR
    Nephrol Dial Transplant; 1990; 5(5):376-8. PubMed ID: 2115629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early acute kidney allograft rejection in patients with triple-drug immunosuppressive treatment.
    Isoniemi H; Eklund B; Häyry P; Höckerstedt K; Korsbäck C; von Willebrand E; Ahonen J
    Transplant Proc; 1988 Jun; 20(3):447-8. PubMed ID: 3289182
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine in the treatment of acute allograft rejection refractory to high-dose methylprednisolone: results of a prospectively randomized trial.
    Margreiter R; Lang A; Koenig P; Kathrein H; Spielberger M; Steiner E; Huber C
    Transplant Proc; 1984 Oct; 16(5):1202-4. PubMed ID: 6385378
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
    S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose vs high-dose methylprednisolone therapy for the treatment of renal allograft rejection.
    Haycock GB; Bewick M; Chantler C; Koffman G; Rigden SP
    Nephrol Dial Transplant; 1990; 5(4):320. PubMed ID: 2113228
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus glomerulitis in a renal allograft.
    Cathro HP; Schmitt TM
    Am J Kidney Dis; 2008 Jul; 52(1):188-92. PubMed ID: 18468750
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.